F

or the fourth time this month, U.K. authorities have opened a new investigation into an unspecified number of drug makers over potential violations of anti-competitive laws concerning generic drugs.

The U.K. Competition and Markets Authority opened the probes into “various parties” regarding “suspected abuse” into “certain generic” medicines, according to statements on the agency web site. The latest probe was opened on Wednesday, while the other three investigations began on Oct. 10. Further details were not disclosed.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.